0.2927
price down icon16.16%   -0.0564
 
loading
Renovaro Inc stock is traded at $0.2927, with a volume of 13.22M. It is down -16.16% in the last 24 hours and down -8.53% over the past month. Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.3491
Open:
$0.34
24h Volume:
13.22M
Relative Volume:
4.40
Market Cap:
$59.33M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.4181
EPS:
-0.7
Net Cash Flow:
$-11.54M
1W Performance:
-14.26%
1M Performance:
-8.53%
6M Performance:
-68.08%
1Y Performance:
-80.49%
1-Day Range:
Value
$0.2927
$0.3481
1-Week Range:
Value
$0.2927
$0.388
52-Week Range:
Value
$0.27
$2.10

Renovaro Inc Stock (RENB) Company Profile

Name
Name
Renovaro Inc
Name
Phone
45 39179840
Name
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Name
Employee
25
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
RENB's Discussions on Twitter

Compare RENB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RENB
Renovaro Inc
0.2927 59.33M 0 -41.23M -11.54M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Renovaro Inc Stock (RENB) Latest News

pulisher
Jun 17, 2025

Renovaro Inc (RENB Stock: A Sea of Opportunity - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Ratios Uncovered: Breaking Down Renovaro Inc (RENB)’s Trailing Twelve Months Metrics - DWinneX

Jun 17, 2025
pulisher
Jun 13, 2025

Renovaro Obtains a U.S. Patent for its AI-Powered Platform for Medication Discovery and Diagnostics - MSN

Jun 13, 2025
pulisher
Jun 10, 2025

Smart Healthcare Is Taking Over. Here's Where the Money's Headed - Finansavisen

Jun 10, 2025
pulisher
Jun 07, 2025

Renovaro Inc. (NASDAQ:RENB) Shares Bought by Nuveen Asset Management LLC - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

POAIRenovaro Issues Shareholder Letter and Provides Corporate Update - Revista ADVFN

Jun 06, 2025
pulisher
Jun 05, 2025

Renovaro Biosciences Subsidiary CEO Resigns Abruptly - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Takes $107,000 Position in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Renovaro subsidiary secures patent for drug discovery AI By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

RENB stock touches 52-week low at $0.27 amid market challenges - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro's BioSymetrics Unit Gets Notice of Allowance for New Patent - MarketScreener

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro (RENB) Secures Patent to Enhance AI in Drug Discovery | - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro Inc. Skyrockets on AI Patent Win: What’s Fueling the Frenzy? - RagingBull

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro (RENB) Secures Patent to Enhance AI in Drug Discovery | RENB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Di - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro subsidiary secures patent for drug discovery AI - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro secures U.S. patent for AI-driven drug discovery, diagnostics platform - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform | RENB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 41,296 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Northern Trust Corp - Defense World

May 31, 2025
pulisher
May 31, 2025

Contrasting Stoke Therapeutics (NASDAQ:STOK) & Renovaro (NASDAQ:RENB) - Defense World

May 31, 2025
pulisher
May 28, 2025

What Analysts Think About Renovaro Inc (NASDAQ: RENB)’s Potential Raise - Stocksregister

May 28, 2025
pulisher
May 28, 2025

Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Predictive Oncology says court denies Renovaro motion for expedited trial - TipRanks

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology (POAI) Addresses Legal Dispute with Renovaro - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | POAI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Delaware Court Rejects Renovaro's Rush to Trial Against Predictive Oncology, Cites Critical Delays - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | P - GuruFocus

May 27, 2025
pulisher
May 23, 2025

Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger - MSN

May 23, 2025
pulisher
May 23, 2025

Major Moves And Shakes In Health Care Sector - Finimize

May 23, 2025
pulisher
May 23, 2025

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge - Nasdaq

May 23, 2025
pulisher
May 22, 2025

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish By Stocktwits - Investing.com India

May 22, 2025
pulisher
May 22, 2025

UPDATERenovaro Inc. Announces Expedited Trial for 2025 Lawsui - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Court Fast-Tracks Renovaro's Lawsuit to Force Merger After Predictive Oncology's $545K Securities Breach - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement D - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Renovaro announces expedited trial on suit to enforce Predictive Oncology merger - TipRanks

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology | RENB Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement - Nasdaq

May 22, 2025

Renovaro Inc Stock (RENB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Renovaro Inc Stock (RENB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
William Anderson Wittekind
10% Owner
Jul 17 '24
Sale
1.46
16,362
23,889
841,433
William Anderson Wittekind
10% Owner
Jul 15 '24
Sale
1.41
21,954
30,955
875,795
William Anderson Wittekind
10% Owner
Jul 10 '24
Sale
1.51
75,000
113,250
894,645
William Anderson Wittekind
10% Owner
Jul 11 '24
Sale
1.51
14,896
22,493
897,749
William Anderson Wittekind
10% Owner
Jul 09 '24
Sale
1.53
4,630
7,084
969,645
William Anderson Wittekind
10% Owner
Jul 05 '24
Sale
1.55
60,000
93,000
974,275
William Anderson Wittekind
10% Owner
Jul 03 '24
Sale
1.51
50,000
75,500
1,034,275
William Anderson Wittekind
10% Owner
Jul 01 '24
Sale
1.56
60,000
93,600
1,118,828
William Anderson Wittekind
10% Owner
Jul 02 '24
Sale
1.54
34,553
53,212
1,084,275
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Cap:     |  Volume (24h):